Quick Answer
Neuraxis, INC reported Research And Development Expense of $493.6 thousand for the year ending 2025.
- Neuraxis, INC showed an increase of +13.8% in Research And Development Expense from 2024 to 2025.
- This data is from Neuraxis, INC's annual report (Form 10-K), filed with the SEC on March 19, 2026.
- XBRL data for this metric is available from 2022 to 2025 (4 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q2 2022: $13.7 thousand | Q3 2022: $86.2 thousand | Q1 2023: $16.8 thousand | Q2 2023: $109.8 thousand | Q3 2023: $45.0 thousand | Q1 2024: $5.6 thousand | Q2 2024: $54.3 thousand | Q3 2024: $126.2 thousand | Q1 2025: $60.6 thousand | Q2 2025: $58.3 thousand | Q3 2025: $130.9 thousand.
- Over the full 4 years of available data (2022 to 2025), Neuraxis, INC's Research And Development Expense has grown by 118.8%.
- Historical annual values: Fiscal year 2025: $493.6 thousand | Fiscal year 2024: $433.6 thousand | Fiscal year 2023: $169.3 thousand | Fiscal year 2022: $225.6 thousand.
- Data sourced from SEC EDGAR public filings as of August 6, 2026.
Last verified: